AKASA Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $120M

  • Investors
  • 14

AKASA General Information

Description

Developer of an intelligent automation technology designed to improve the healthcare revenue cycle. The company's tool analyzes the historical data, which allows the development of new flows to eliminate manual work and drive efficiency and performance gains for healthcare institutions, enabling clients to solve the drawbacks faced due to financial failures.

Contact Information

Website
www.akasa.com
Formerly Known As
Alpha Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 Oyster Point Boulevard
  • Suite 222
  • San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 400 Oyster Point Boulevard
  • Suite 222
  • San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AKASA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 24-Feb-2022 $120M Completed Generating Revenue
3. Early Stage VC (Series B) 23-Mar-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Nov-2019 $20M $25M Completed Generating Revenue
1. Seed Round 20-Dec-2018 $5M $5M Completed Startup
To view AKASA’s complete valuation and funding history, request access »

AKASA Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 3,940,420 $0.000010 6% $5.08 $5.08 1x $5.08 13.64%
Seed 2,571,484 $0.000010 6% $1.94 $1.94 1x $1.94 8.9%
To view AKASA’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AKASA Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an intelligent automation technology designed to improve the healthcare revenue cycle. The company's tool a
Enterprise Systems (Healthcare)
San Francisco, CA
200 As of 2024

Boston, MA
 

Tampa, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AKASA Competitors (6)

One of AKASA’s 6 competitors is CodaMetrix, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CodaMetrix Venture Capital-Backed Boston, MA
Greenway Health Private Equity-Backed Tampa, FL
Jorie Advanced Automation Corporation Oak Brook, IL
AGS Health Private Equity-Backed Washington, DC
CareCloud Corporation Somerset, NJ
To view AKASA’s complete competitors history, request access »

AKASA Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

AKASA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260024634-A1 System and/or method for determining service codes from electronic signals and/or states Pending 17-Jul-2024
US-20220383130-A1 System, devices and/or processes for self-supervised machine-learning Inactive 27-May-2021
WO-2022251493-A1 System, devices and/or processes for self-supervised machine-learning Inactive 27-May-2021
US-20240013564-A1 System, devices and/or processes for training encoder and/or decoder parameters for object detection and/or classification Inactive 27-May-2021
US-12009071-B2 System and/or method for determining service codes from electronic signals and/or states using machine learning Active 20-Nov-2020 G16H10/60
To view AKASA’s complete patent history, request access »

AKASA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AKASA Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andreessen Horowitz Venture Capital Minority
Coatue Management PE/Buyout Minority
Cultural Leadership Fund Venture Capital Minority
Fog Ventures (San Francisco) Venture Capital Minority
BOND Capital (San Francisco) Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

AKASA FAQs

  • When was AKASA founded?

    AKASA was founded in 2018.

  • Where is AKASA headquartered?

    AKASA is headquartered in San Francisco, CA.

  • What is the size of AKASA?

    AKASA has 200 total employees.

  • What industry is AKASA in?

    AKASA’s primary industry is Enterprise Systems (Healthcare).

  • Is AKASA a private or public company?

    AKASA is a Private company.

  • What is the current valuation of AKASA?

    The current valuation of AKASA is .

  • What is AKASA’s current revenue?

    The current revenue for AKASA is .

  • How much funding has AKASA raised over time?

    AKASA has raised $205M.

  • Who are AKASA’s investors?

    Andreessen Horowitz, Coatue Management, Cultural Leadership Fund, Fog Ventures (San Francisco), and BOND Capital (San Francisco) are 5 of 14 investors who have invested in AKASA.

  • Who are AKASA’s competitors?

    CodaMetrix, Greenway Health, Jorie Advanced Automation, AGS Health, and CareCloud are some of the 6 competitors of AKASA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process